Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 06, 2022

SELL
$7.33 - $9.32 $930 - $1,183
-127 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$7.01 - $11.37 $890 - $1,443
127 New
127 $1,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.